-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Aridis Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2017 to Q4 2022.
- Aridis Pharmaceuticals, Inc. Deferred Tax Assets, Gross for the quarter ending December 31, 2022 was $34.1M, a 19.4% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)